Skip to main content
RNAC logo

RNAC · Cartesian Therapeutics, Inc. · Analyst Estimates

Track RNAC — free
$8.19 -0.24 (-2.85%) At close · Sep 11
Market Cap
$247.79M
Shares
30.26M

Analyst Estimates

Compare analyst forecasts for Cartesian Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1453687 CUSIP 816212302 13F (30d) 36 filings 36 filers Visit website Investor relations